Norris Perne & French LLP Thermo Fisher Scientific Inc. Transaction History

Norris Perne & French LLP

$1.36 Billion
Q3 2024

A detailed history of Norris Perne & French LLP transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Norris Perne & French LLP holds 35,765 shares of TMO stock, worth $18.9 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

35,765

Previous 36,055 0.8%

Holding current value

$18.9 Million

Previous $19.9 Million 10.95%

% of portfolio

1.63%

Previous 1.54%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$531.86 - $624.21 $154,239 - $181,020	-290 Reduced 0.8%	35,765 $22.1 Million
Q2 2024 Jul 24, 2024	BUY	$541.52 - $599.02 $146,751 - $162,334	271 Added 0.76%	36,055 $19.9 Million
Q1 2024 Apr 16, 2024	SELL	$528.82 - $599.43 $521,416 - $591,037	-986 Reduced 2.68%	35,784 $20.8 Million
Q4 2023 Jan 22, 2024	BUY	$431.41 - $532.94 $4.73 Million - $5.84 Million	10,962 Added 42.48%	36,770 $19.5 Million
Q3 2023 Oct 18, 2023	BUY	$498.29 - $574.41 $112,115 - $129,242	225 Added 0.88%	25,808 $13.1 Million
Q2 2023 Jul 19, 2023	BUY	$508.46 - $591.13 $435,241 - $506,007	856 Added 3.46%	25,583 $13.3 Million
Q1 2023 Apr 20, 2023	SELL	$535.0 - $604.82 $24,610 - $27,821	-46 Reduced 0.19%	24,727 $14.3 Million
Q4 2022 Jan 24, 2023	SELL	$484.71 - $571.37 $347,052 - $409,100	-716 Reduced 2.81%	24,773 $0
Q3 2022 Oct 13, 2022	BUY	$507.19 - $604.49 $110,060 - $131,174	217 Added 0.86%	25,489 $12.9 Million
Q2 2022 Aug 11, 2022	BUY	$500.9 - $612.21 $130,734 - $159,786	261 Added 1.04%	25,272 $13.7 Million
Q1 2022 Apr 26, 2022	BUY	$524.0 - $644.92 $40,872 - $50,303	78 Added 0.31%	25,011 $14.8 Million
Q4 2021 Jan 26, 2022	SELL	$569.0 - $667.24 $519,497 - $609,190	-913 Reduced 3.53%	24,933 $16.6 Million
Q3 2021 Oct 26, 2021	BUY	$509.53 - $609.78 $185,468 - $221,959	364 Added 1.43%	25,846 $14.8 Million
Q2 2021 Jul 20, 2021	SELL	$441.0 - $508.24 $3.65 Million - $4.21 Million	-8,283 Reduced 24.53%	25,482 $12.9 Million
Q1 2021 Apr 30, 2021	SELL	$439.85 - $518.83 $2.74 Million - $3.23 Million	-6,219 Reduced 15.55%	33,765 $15.4 Million
Q4 2020 Jan 27, 2021	SELL	$435.06 - $527.66 $45,246 - $54,876	-104 Reduced 0.26%	39,984 $18.6 Million
Q3 2020 Oct 26, 2020	SELL	$359.77 - $441.52 $48,928 - $60,046	-136 Reduced 0.34%	40,088 $17.7 Million
Q2 2020 Jul 23, 2020	BUY	$275.2 - $362.34 $39,904 - $52,539	145 Added 0.36%	40,224 $14.6 Million
Q1 2020 Apr 16, 2020	SELL	$255.3 - $340.05 $3.65 Million - $4.86 Million	-14,287 Reduced 26.28%	40,079 $11.4 Million
Q4 2019 Jan 22, 2020	BUY	$271.93 - $328.04 $59,008 - $71,184	217 Added 0.4%	54,366 $17.7 Million
Q3 2019 Oct 24, 2019	SELL	$268.46 - $305.43 $441,079 - $501,821	-1,643 Reduced 2.94%	54,149 $15.8 Million
Q2 2019 Jul 19, 2019	BUY	$257.51 - $295.55 $97,853 - $112,309	380 Added 0.69%	55,792 $16.4 Million
Q1 2019 Apr 29, 2019	SELL	$212.17 - $273.72 $213,655 - $275,636	-1,007 Reduced 1.78%	55,412 $15.2 Million
Q4 2018 Jan 28, 2019	SELL	$208.47 - $251.98 $60,456 - $73,074	-290 Reduced 0.51%	56,419 $12.6 Million
Q3 2018 Oct 29, 2018	BUY	$205.57 - $244.32 $33,713 - $40,068	164 Added 0.29%	56,709 $13.8 Million
Q2 2018 Jul 24, 2018	SELL	$203.14 - $219.53 $280,739 - $303,390	-1,382 Reduced 2.39%	56,545 $11.7 Million
Q1 2018 Apr 17, 2018	BUY	$192.98 - $224.11 $37,824 - $43,925	196 Added 0.34%	57,927 $12 Million
Q4 2017 Jan 23, 2018	BUY	$182.03 - $200.37 $807,121 - $888,440	4,434 Added 8.32%	57,731 $11 Million
Q3 2017 Nov 01, 2017	BUY	$171.74 - $194.04 $9.15 Million - $10.3 Million	53,297	53,297 $10.1 Million

Others Institutions Holding TMO

# of Institutions

2,835

Shares Held

333M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $207B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

News

Stay updated on Norris Perne & French LLP with notifications on news.

Account

Norris Perne & French LLP Thermo Fisher Scientific Inc. Transaction History